By A.M.D. via Flickr
Health News Review examines stories from the Associated Press and Reuters on a new stent for treating coronary artery disease. The reviewers praise the AP version but not the Reuters story: "Its almost giddy approach to the FDA announcement belies the fact that long-term safety and efficacy data are not yet in hand. Put another way, no one yet knows if these dissolvable stents will make a practical difference in heart disease patient outcomes."